How Often Pharmacists Work with OIC Patients

Article
Conference|PainWeek

Mary M. Bridgeman, PharmD, BCPS, CGP, discusses how often pharmacists work with OIC patients.

Mary

M.

Bridgeman

, PharmD, BCPS, CGP, discusses how often pharmacists work with OIC patients.

Related Videos
Image credit: Dr_Microbe | stock.adobe.com
Home Diabetes Treatment - Image credit: Dglimages | stock.adobe.com
Image credit: Azee/peopleimages.com | stock.adobe.com
Cropped view of senior man playing with puzzles on table- Image credit: LIGHTFIELD STUDIOS | stock.adobe.com
Breast cancer with lymphatics, medically 3D illustration | Image Credit: Axel Kock - stock.adobe.com
Woman with pink ribbon on color background. Breast cancer awareness concept | Image Credit: Pixel-Shot - stock.adobe.com
Pharmacy, medicine and senior woman consulting pharmacist on prescription. Healthcare, shopping and elderly female in consultation with medical worker for medication box, pills or product in store- Image credit: C Daniels/peopleimages.com | stock.adobe.com
View in microscopic of pathology cross section tissue ductal cell carcinoma or adenocarcinoma diagnosis by pathologist in laboratory | Image Credit: arcyto - stock.adobe.com
A female doctor sits at her desk and talks to a female patient while looking at her mammogram | Image Credit: lordn - stock.adobe.com
Related Content
Women with cancer receiving treatment

No Significant Differences at 5 Year Follow-Up Between Palbociclib-Based Treatment Regimens

December 8th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 2

Pharmacy Focus: Conversations On Reproductive Health - Episode 2

November 29th 2023
Podcast
The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

The Future of Immunotherapy in Breast Cancer Involves Engineered T-Cell Therapies, Better Prediction of Adverse Effects

December 8th 2023
Article
Pharmacy Focus: Conversations On Reproductive Health - Episode 1

Pharmacy Focus: Conversations On Reproductive Health - Episode 1

November 15th 2023
Podcast
Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

Tucatinib, Trastuzumab Combination Improves Progression-Free Survival in HER2+, Locally Advanced or Metastatic Breast Cancer

December 7th 2023
Article
Adding Pembrolizumab to Chemotherapy Increased Pathological Complete Response, Improved Residual Cancer Burden in Early-Stage, High-Risk ER+/HER2- Breast Cancer

Adding Pembrolizumab to Chemotherapy Increased Pathological Complete Response, Improved Residual Cancer Burden in Early-Stage, High-Risk ER+/HER2- Breast Cancer

December 7th 2023
Article
© 2023 MJH Life Sciences

All rights reserved.